GeneDx Corp. (WGS)

NASDAQ: WGS · Real-Time Price · USD

67.12

4.80 (7.70%)

At close: May 02, 2025, 3:59 PM

66.99

-0.20%

After-hours: May 02, 2025, 05:58 PM EDT

GeneDx Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-52.29M	-175.77M	-548.98M	-245.39M	-241.34M	-29.7M
Depreciation & Amortization	21.95M	35.83M	59.31M	21.81M	11.73M	6.41M
Stock-Based Compensation	9.14M	-326K	41.98M	219.42M	120.23M	5.48M
Other Working Capital	n/a	-2.53M	-8.46M	123K	-1M	1.42M
Other Non-Cash Items	-6.96M	-721K	141.53M	1.62M	2.4M	-176K
Deferred Income Tax	-343K	-926K	-49.12M	-195.97M	n/a	n/a
Change in Working Capital	n/a	-38.24M	36.13M	8.08M	13.85M	-737K
Operating Cash Flow	-28.5M	-180.15M	-319.15M	-190.43M	-93.13M	-18.73M
Capital Expenditures	-5.49M	-5.71M	-14.32M	-20.79M	-31.97M	-15.46M
Cash Acquisitions	n/a	-8.11M	-127M	n/a	n/a	n/a
Purchase of Investments	-66.3M	-47.67M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	41.66M	17.77M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-1	n/a	n/a	n/a	n/a
Investing Cash Flow	-30.13M	-43.73M	-141.33M	-20.79M	-31.97M	-15.46M
Debt Repayment	-3.23M	42.95M	-3.29M	-13.47M	11.73M	-1.71M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	891K	285K	2.95M	65.05M	n/a	30.9M
Financial Cash Flow	44.16M	186.24M	197.31M	493.73M	129.06M	148.01M
Net Cash Flow	-14.47M	-37.72M	-263.17M	282.51M	3.95M	113.83M
Free Cash Flow	-33.99M	-185.86M	-333.48M	-211.22M	-125.1M	-34.18M